264 related articles for article (PubMed ID: 17713765)
1. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
[TBL] [Abstract][Full Text] [Related]
2. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
Nakajo M; Jinnouchi S; Noguchi M; Uozumi K; Tanabe H; Tateno R; Nakajo M
Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET/CT findings of autoimmune pancreatitis.
Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206
[TBL] [Abstract][Full Text] [Related]
4. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings.
Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L
Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis.
Otsuka H; Morita N; Yamashita K; Nishitani H
Ann Nucl Med; 2007 Dec; 21(10):593-6. PubMed ID: 18092136
[TBL] [Abstract][Full Text] [Related]
7. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
[TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
Ohtani M; Ofuji K; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Takahashi K; Naito T; Matsuda H; Hiramatsu K; Nakamoto Y
Pancreas; 2021 Aug; 50(7):1014-1019. PubMed ID: 34629452
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
11. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
12.
Zhang J; Jia G; Zuo C; Jia N; Wang H
BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
[TBL] [Abstract][Full Text] [Related]
13. Metachronous extrapancreatic lesions in autoimmune pancreatitis.
Takuma K; Kamisawa T; Anjiki H; Egawa N; Igarashi Y
Intern Med; 2010; 49(6):529-33. PubMed ID: 20228586
[TBL] [Abstract][Full Text] [Related]
14. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Sato M; Okumura T; Shioyama Y; Imura J
Ann Nucl Med; 2008 Apr; 22(3):215-9. PubMed ID: 18498037
[TBL] [Abstract][Full Text] [Related]
15. Abdominal extrapancreatic lesions associated with autoimmune pancreatitis: radiological findings and changes after therapy.
Sohn JH; Byun JH; Yoon SE; Choi EK; Park SH; Kim MH; Lee MG
Eur J Radiol; 2008 Sep; 67(3):497-507. PubMed ID: 17904325
[TBL] [Abstract][Full Text] [Related]
16. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
17. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
Ferda J; Ferdová E; Záhlava J; Walter J; Mukensnabl P; Daum O; Kreuzberg B
Eur J Radiol; 2010 Feb; 73(2):241-8. PubMed ID: 19101104
[TBL] [Abstract][Full Text] [Related]
19. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.
Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP
Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
